NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...

Beyond Supply Chain: AI-Powered Innovations for Trial Optimization Alongside Clinical Supply Chain On Demand, Good AI and Intrinseque Health are introducing AI-powered solutions for protocol ...

QuantHealth, an AI-powered drug development platform trusted by the largest pharmaceutical companies, today announced registration has opened for its annual AI in Clinical Development Summit, which ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

This collaboration with Intrinseque Health allows us to introduce AI-driven logistics automation and real-time supply optimization, making clinical trial execution more predictable and cost ...

Generative artificial intelligence (generative AI or gen AI) in healthcare, has been in the spotlight for the last few years ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

We recently published a list of the 12 Best AI Stocks to Invest in According to Reddit. In this article, we are going to take ...

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...